Co-existent endometrial and ovarian carcinoma: molecular and pathological features define low risk entity Article Swipe
Related Concepts
Medicine
Pathological
Carcinoma
Oncology
Gynecology
Ovarian carcinoma
Internal medicine
Ovarian cancer
Cancer
Amy Jamieson
,
Jutta Huvila
,
Samuel Leung
,
Marcel Grube
,
Andrea Neilson
,
Niki Boyd
,
Derek S. Chiu
,
Mehrane Nazeran
,
Michael S. Anglesio
,
Janine Senz
,
Amy Lum
,
Stefan Kommoss
,
David G. Huntsman
,
C. Blake Gilks
,
Jessica N. McAlpine
·
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.1016/j.ijgc.2025.101957
· OA: W4410816600
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.1016/j.ijgc.2025.101957
· OA: W4410816600
FIGO IA3 criteria identify a subset of co-existent endometrial and ovarian carcinomas with excellent outcomes. However, incorporating molecular features into the definition enables greater prognostic discernment and supports the inclusion of patients with a broader range of pathologic features with indolent disease (increased from 20% to 49% of the cohort, 0 recurrences) who may be candidates for treatment de-escalation.
Related Topics
Finding more related topics…